| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 10/08/2008 | CN101279071A Chinese medicinal composition for curing esophagus cancer or cardiac cancer |
| 10/08/2008 | CN101279068A Chinese medicinal composition for treating leukemia and preparation method thereof |
| 10/08/2008 | CN101279040A Chinese medicinal active anti-cancer vaccine and method of preparing the same |
| 10/08/2008 | CN101278993A Method for extracting triterpenes from jujube fruit |
| 10/08/2008 | CN101278989A Method for extracting Thalictrum aquilegifolium total alkaloids and total saponins from Thalictrum aquilegifolium |
| 10/08/2008 | CN101278968A Compound preparations with anticancer auxiliary function |
| 10/08/2008 | CN101278957A Application of extract of Gynura Divaricata in anti-cancer medicine |
| 10/08/2008 | CN101278954A Ginseng or American ginseng product with increased content of ginseng saponin Rg3 and method of preparing the same |
| 10/08/2008 | CN101278949A Composition and its preparation and application |
| 10/08/2008 | CN101278947A Yellow-back fungus fermentation product, composition containing the fermentation product and preparation method thereof |
| 10/08/2008 | CN101278941A Use of 5-substituted nucleosides for reinforcing the apoptotic effect of cytostatic drugs |
| 10/08/2008 | CN101278925A Application of embellin in preparation of medicament for inhibiting angiogenesis |
| 10/08/2008 | CN100424182C Methods for detecting and treating the early onset of aging-related conditions |
| 10/08/2008 | CN100424175C Methods and compositions for treating neoplasms by ERBB3 |
| 10/08/2008 | CN100424096C Survivin mutant containing HIV transduction structural area and its preparation method and uses |
| 10/08/2008 | CN100424094C Pharmaceutical compositions, and a method of preparing and isolating said pharmaceutical compositions, and use of said pharmaceutical compositions for prophylactic treatment of lesions and carcinomas |
| 10/08/2008 | CN100424079C Bis-sulfonamides |
| 10/08/2008 | CN100423779C Medicinal composition comprising active components of 5-HT 3 receptor antagonist and H2 receptor antagonist and use thereof |
| 10/08/2008 | CN100423778C Folic acid receptor targeted liposome medicine carrier, its preparation and application |
| 10/08/2008 | CN100423777C Glycoprotein compositions |
| 10/08/2008 | CN100423776C Therapeutic agent |
| 10/08/2008 | CN100423765C Medicine for curing lung cancer |
| 10/08/2008 | CN100423762C Chinese medicine for treating malignant tumors |
| 10/08/2008 | CN100423741C Compound Chinese medicine prepn for treating malignant tumor |
| 10/08/2008 | CN100423727C Antineoplastic composition, and process for preparing the same |
| 10/08/2008 | CN100423719C Nano granules of Docetaxel and preparing method |
| 10/08/2008 | CN100423714C Elemene injection, and preparing method and use thereof |
| 10/08/2008 | CN100423713C Curcuma aromatica extract injection, and preparing method and use thereof |
| 10/07/2008 | US7432374 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 10/07/2008 | US7432370 Mixing a racemic mixture of enantiomers of pyrrolo[2,3-d]pyrimidine compounds in a solvent, with a resolving compound having a defined stereospecificity, to form a solution and with resolving agent being capable of binding with enantiomers to form a precipitate collecting precipitate and purifying |
| 10/07/2008 | US7432364 Polynucleotide which encodes human antibody that binds to tissue inhibitors of metalloproteases; used to diagnose and treat liver & cardiac fibrosis, alcoholic liver disease, acute coronary syndrome, lupus nephritis, glomerulosclerotic renal disease, benign prostate hypertrophy, colon and lung cancer |
| 10/07/2008 | US7432358 Oncogene, recombinant protein derived therefrom, and uses thereof |
| 10/07/2008 | US7432354 Polypeptide or fragment recognized by tumor-specific cytotoxic T lymphocytes; anticancer vaccines |
| 10/07/2008 | US7432304 Providing cell which overexpresses a Bcl-2 family protein; gossypol compound; treating with cell with an effective amount of gossypol compound under conditions such that apoptosis in cell is modulated |
| 10/07/2008 | US7432303 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states |
| 10/07/2008 | US7432299 Use of alpha-2-delta ligands such as gabapentin, pregabalin and other alpha-2-delta ligands such as [6-(Aminomethyl)bicyclo[3.2.0]hept-6-yl]acetic acid; treatment of premature ejaculation |
| 10/07/2008 | US7432292 Anticancer agents; autoimmune diseases; antiinflammatory agents; ; graft versus host disease; Crohn's diseases; skin disorders |
| 10/07/2008 | US7432290 Claimed is 1-Cyanobutan-2-yl-1-[3-[3-[3-methoxy-4-(oxazol-5-yl)phenyl]ureido]phenyl] ethylcarbamate, AVN 944, VX-944 |
| 10/07/2008 | US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors |
| 10/07/2008 | US7432286 Pharmaceutically active sulfonyl hydrazide derivatives |
| 10/07/2008 | US7432285 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 10/07/2008 | US7432270 N-aroyl cyclic amines |
| 10/07/2008 | US7432268 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 10/07/2008 | US7432265 Imidazopyrazines as cyclin dependent kinase inhibitors |
| 10/07/2008 | US7432263 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 10/07/2008 | US7432260 Pyrimidine compounds |
| 10/07/2008 | US7432253 Phosphoepoxides, method for making same and uses |
| 10/07/2008 | US7432246 Sir2 products and activities |
| 10/07/2008 | US7432244 Administering peptides useful in treating disorders caused or mediated by insulin-like growth factors, such as cancer, diabetic complications, acromegaly, age-related macular degeneration, ischemic injuries, or traumas |
| 10/07/2008 | US7432243 A nucleic acid molecule that encodes at least one polypeptide useful as antiangiogenic, tumor suppressive and antimigratory agent |
| 10/07/2008 | US7432240 Fumaric acid amides |
| 10/07/2008 | US7432059 Methods of identifying compounds that upmodulate T cell activation in the presence of a PD-1 mediated signal |
| 10/07/2008 | US7431946 Method for producing extracts of Boehmeria frutescens thunberg or Boehmeria nivea for hepatitis treatment |
| 10/07/2008 | US7431925 Internal image antibodies for optical imaging and therapy |
| 10/07/2008 | CA2444071C Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 10/07/2008 | CA2433772C Pyrimidine matrix metalloproteinase inhibitors |
| 10/07/2008 | CA2426009C Cholesterol lowering benzo[b]thiophenes and benzo[d]isothiazoles |
| 10/07/2008 | CA2416685C Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 10/07/2008 | CA2411544C N-alkyl-adamantyl triazinyl benzamide derivatives |
| 10/07/2008 | CA2410232C Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer |
| 10/07/2008 | CA2392971C 2,4-diaminopyrimidine compounds useful as immunosuppressants |
| 10/07/2008 | CA2362582C Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases |
| 10/07/2008 | CA2359872C Gels formed by the interaction of poly(aldehyde) with various substances |
| 10/07/2008 | CA2350834C N-terminally truncated her-2/neu protein as a cancer prognostic indicator |
| 10/07/2008 | CA2350815C Stable amorphous amifostine compositions and methods for the preparation and use of same |
| 10/07/2008 | CA2335300C Macrocyclic analogs and methods and their use and preparation |
| 10/07/2008 | CA2331461C Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis |
| 10/07/2008 | CA2305926C Stable crystalline salts of 5-methyltetrahydrofolic acid |
| 10/07/2008 | CA2296067C Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue |
| 10/07/2008 | CA2280715C Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp.infection |
| 10/07/2008 | CA2259984C Precise efficacy assay methods for active agents including chemotherapeutic agents |
| 10/07/2008 | CA2209426C Human pak65 |
| 10/04/2008 | WO2008127226A2 P13 kinase antagonists |
| 10/04/2008 | CA2639579A1 Pi3 kinase antagonists |
| 10/02/2008 | WO2008119071A1 Modulation of tumor microenvironment |
| 10/02/2008 | WO2008118847A1 Composition and method for treating cancer |
| 10/02/2008 | WO2008118792A2 Gamma delta t cells and methods of treatment of interleukin-17 related conditions |
| 10/02/2008 | WO2008118733A2 Methods of treating cancer by administering human il-18 combinations |
| 10/02/2008 | WO2008118468A1 Heterocyclic compounds and their uses |
| 10/02/2008 | WO2008118454A2 Derivatives of quinoline or benzopyrazine and their uses for the treatment of (inter alia) inflammatory diseases, autoimmune diseases or various kinds of cancer |
| 10/02/2008 | WO2008118369A2 Methods for inducing a natural killer (nk) cell-mediated immune response and for increasing nk cell activity |
| 10/02/2008 | WO2008117970A1 Use of inhibitors of leukotriene b4 receptor blt2 for treating human cancers |
| 10/02/2008 | WO2008117862A1 Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure |
| 10/02/2008 | WO2008117815A1 Inhibitor for cell death caused by endoplasmic reticulum stress or oxidation stress |
| 10/02/2008 | WO2008117814A1 Oral pharmaceutical preparation for colon-specific delivery |
| 10/02/2008 | WO2008117775A1 Taxanes having oxetane ring structure |
| 10/02/2008 | WO2008117303A1 Indole derivatives and their metal conjugates and uses thereof |
| 10/02/2008 | WO2008117061A2 Tetrahydroisoquinolines as tumour growth inhibitors |
| 10/02/2008 | WO2008117051A1 S-6-meth0xy-2- (2- (3- (pyrimid-2-yl) is0xaz0l-5-yl) pyrrolidin-1-yl) -4- (5-methyl-ih-pyrazol-s-ylamino) pyrimidine and polymorphic forms thereof as modulators of the insulin-like growth |
| 10/02/2008 | WO2008117050A1 Pyrazolyl-amino-substituted pyrazines and their use for the treatment of cancer |
| 10/02/2008 | WO2008117049A1 Human anti cd166 antibody binding human tumor cells |
| 10/02/2008 | WO2008116665A1 Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists |
| 10/02/2008 | WO2008116641A2 Oleyl phosphocholine |
| 10/02/2008 | WO2008116470A1 Enhancing pulmonary host defence via administration of granulocyte- colony stimulating factor |
| 10/02/2008 | WO2008116347A1 Methods for promoting protection and regeneration of bone marrow using cxcl9 and anti-cxcl9 antibodies |
| 10/02/2008 | WO2008116316A1 Vector encoding therapeutic polypeptide and safety elements to clear transduced cells |
| 10/02/2008 | WO2008116299A1 Cancer disease modifying antibody 010207-01 produced by hybridoma cell line ar51a630.3. |
| 10/02/2008 | WO2008116293A1 Multivalent heterobifunctional polymers and methods of their use |
| 10/02/2008 | WO2008116262A1 Methods and compositions for treating prostate cancer |
| 10/02/2008 | WO2008100618A3 Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s |